A recent study indicates that people who stop using new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who stop conventional diet and exercise regimens.
Published data in a prominent health publication demonstrates that while obese people can lose about a fifth of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month after stopping.
"Users purchasing such medications need to be informed of the risk of rapid weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.
That rate of regain suggests a return to starting mass within about one and a half years.
Weighing Therapies
The study, which examined 37 of studies involving thousands of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers note that individuals who shed pounds through diet and exercise typically see a more gradual creep back—around 100 grams monthly—post-intervention.
The Reason for the Quick Rebound
Experts suggest the mechanism of the jabs explains the heightened regain.
These medications mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels far above than normal might result in the body to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in hunger is unsuppressed, making binge eating far more likely."
A Chronic Issue?
Health authorities suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, considering the significant potential of weight regain, the therapy might need to be long-term.
This opinion is echoed by pharmaceutical companies, who say that the findings "emphasize the chronic nature of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Users who have come off the jabs describe a sudden resurgence of cravings.
"It was like a trigger that goes on and I was suddenly ravenous," said one woman.
This difficulty is exacerbated if patients have not adopted sustainable lifestyle or habit changes during treatment.
Widespread Interest
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest being substantial.
- Use is more common among females than males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
In conclusion, researchers caution that while these medications are effective agents for shedding pounds, they are not a magic solution and maintained weight loss relies on integrated behavioural management.
